Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
395 patents granted to the 23 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Zoetis Inc.’s names, not what it holds today.
Patents granted
395
389 utility, 4 design, 2 reissue, 1976 to Dec 31, 2025
Granted in 2025
26
Against 24 in 2024 and 12 in 2023
Applications published
404
30 of them in 2025
Names they are printed under
23
a subsidiary, its own name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals58
Analysis of biological materials14
Other special machines7
Biotechnology7
Measurement7
Organic fine chemistry7
Chemical engineering4
Handling2
Medical technology2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name23 counted
Zoetis Services LLC a subsidiary
named as the applicant on its applications, in US
0 granted
225 publishedZoetis Services LLC a subsidiary
US, as the owner printed on each patent
218 granted
6 publishedEmbrex, Inc. a subsidiary
US, as the owner printed on each patent
65 granted
20 publishedAbaxis, Inc. a subsidiary
US, as the owner printed on each patent
60 granted
15 publishedZoetis LLC its own name
US, as the owner printed on each patent
26 granted
18 publishedZoetis LLC its own name
named as the applicant on its applications, in US
0 granted
37 publishedABAXIS, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
31 publishedAlpharma, LLC a subsidiary
US, as the owner printed on each patent
2 granted
16 publishedPharmaq AS a subsidiary
named as the applicant on its applications, in NO
0 granted
9 publishedJUROX PTY LTD a subsidiary
AU, as the owner printed on each patent
5 granted
3 publishedPharmaq AS a subsidiary
NO, as the owner printed on each patent
6 granted
0 publishedPlatinum Performance, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
6 publishedZoetis Belgium S.A a subsidiary
BE, as the owner printed on each patent
6 granted
0 publishedJUROX PTY LTD a subsidiary
named as the applicant on its applications, in AU
0 granted
4 publishedZOETIS DENMARK APS a subsidiary
DK, as the owner printed on each patent
3 granted
1 publishedBASEPAWS a subsidiary
named as the applicant on its applications, in US
0 granted
3 publishedZOETIS CANADA INC. a subsidiary
CA, as the owner printed on each patent
3 granted
0 publishedZoetis Belgium S.A. a subsidiary
named as the applicant on its applications, in BE
0 granted
3 publishedAL Pharma, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
2 publishedAdivo GmbH a subsidiary
DE, as the owner printed on each patent
1 granted
1 publishedadivo GmbH a subsidiary
named as the applicant on its applications, in DE
0 granted
2 publishedVIRTUAL RECALL LIMITED a subsidiary
GB, as the owner printed on each patent
0 granted
1 publishedZOETIS CANADA INC. a subsidiary
named as the applicant on its applications, in CA
0 granted
1 published
Names not counted (2)
Alpharma, LLC
Most of its patents print NO; this name counts in US. 1 granted and 2 published under it are not counted.
Zoetis Belgium S.A.
Most of its patents print US; this name counts in BE. 1 granted and 0 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Dec 16, 2025 | 12,497,459 | Nucleic acids encoding canine anti-NGF antibodies and methods thereof | Pharmaceuticals | Zoetis Services LLC |
| Nov 4, 2025 | 12,458,001 | Singulating device for organisms | Other special machines | Zoetis Services LLC |
| Oct 14, 2025 | 12,440,556 | Genetically modified cell line for production of Marek's disease virus vaccine and methods of making and using the same | Biotechnology | Zoetis Services LLC |
| Sep 23, 2025 | 12,419,941 | Poultry drinking water-based vaccine delivery system and method | Pharmaceuticals | Zoetis Services LLC |
| Aug 19, 2025 | 12,390,441 | Immunomodulating o-het/aryl azalides | Pharmaceuticals | Zoetis Services LLC |
| Aug 19, 2025 | 12,390,440 | Immunomodulating trifluoromethyl-aminal azalides | Pharmaceuticals | Zoetis Services LLC |
| Aug 5, 2025 | 12,378,233 | Immunomodulating azalides | Organic fine chemistry | Zoetis Services LLC |
| Jul 8, 2025 | 12,350,328 | Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (EIV) in horses | Pharmaceuticals | Zoetis Services LLC |
| Jul 1, 2025 | 12,344,659 | Canine antibody libraries | Biotechnology | Adivo GmbH |
| Jul 1, 2025 | 12,343,402 | Method of determining the identity and/or amount of an anti-IL-31 antibody in a sample | Pharmaceuticals | Zoetis Services LLC |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Oct 30, 2025 | 2025/0332243 | METHODS OF MANUFACTURING PORCINE ENDOGENOUS RETROVIRUS (PERV) FREE ANIMAL HEALTH VACCINES | Pharmaceuticals | Zoetis Services LLC |
| Oct 30, 2025 | 2025/0332242 | PORCINE ENDOGENOUS RETROVIRUS (PERV)-FREE PORCINE CIRCOVIRUS TYPE 2D-BASED VACCINES AND METHODS OF USE | Pharmaceuticals | Zoetis Services LLC |
| Oct 23, 2025 | 2025/0325685 | PEPTIDE VACCINES AGAINST INTERLEUKIN-31 | Pharmaceuticals | Zoetis Services LLC |
| Oct 9, 2025 | 2025/0312431 | VACCINES AGAINST MORITELLA VISCOSA | Pharmaceuticals | Zoetis Services LLC |
| Sep 25, 2025 | 2025/0295752 | VACCINE AGAINST INFECTIOUS BRONCHITIS | Pharmaceuticals | Zoetis Services LLC |
| Sep 25, 2025 | 2025/0295732 | COMPOSITIONS AND METHODS FOR ACTIVATING INNATE IMMUNITY | Pharmaceuticals | Zoetis Services LLC |
| Sep 4, 2025 | 2025/0276967 | HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES | Organic fine chemistry | Zoetis LLC |
| Aug 28, 2025 | 2025/0270661 | NOVEL FISH TOTIVIRUS | Biotechnology | Pharmaq AS |
| Jul 24, 2025 | 2025/0236616 | IMMUNOMODULATING AZALIDES | Organic fine chemistry | Zoetis Services LLC |
| Jun 26, 2025 | 2025/0206832 | Anti-NGF Antibodies and Methods Thereof | Pharmaceuticals | Zoetis Services LLC |
What it applied for, 2024 to 2025: Pharmaceuticals 32 · Biotechnology 11 · Organic fine chemistry 4 · Other special machines 3 · Analysis of biological materials 2 · Medical technology 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.